Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer

Ann Transl Med. 2022 Apr;10(7):389. doi: 10.21037/atm-21-6999.

Authors

Roberta Maltoni¹, Sara Bravaccini¹

Affiliation

¹ IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

No abstract available

Publication types

Editorial
Comment